ANAB
ANAB
AnaptysBio, Inc.
$67.51
+$0.61 (+0.91%)
Mkt Cap: $1.94B
Home / ANAB / Financial Statements

AnaptysBio, Inc. (ANAB) Financial Statements

🤖 Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$234.60M
$234.60M ↑157.0%
$91.28M ↑432.0%
$17.16M ↑66.8%
$10.29M ↓83.7%
$63.17M
Cost of Revenue
$2.42M
$2.42M ↓98.5%
$163.84M ↑23.9%
$132.28M ↑49.0%
$88.80M ↓9.8%
$98.50M
Gross Profit
$232.18M
$232.18M ↑420.0%
-$72.56M ↑37.0%
-$115.13M ↓46.6%
-$78.51M ↓122.3%
-$35.32M
R&D Expenses
$135.97M
$135.97M ↓17.0%
$163.84M ↑17.3%
$139.62M ↑57.2%
$88.80M ↓9.8%
$98.50M
SG&A Expenses
$50.74M
$50.74M ↑19.7%
$42.39M ↑1.1%
$41.95M ↑14.5%
$36.64M ↑70.5%
$21.49M
Operating Income
$47.90M
$47.90M ↑141.7%
-$114.95M ↑30.1%
-$164.41M ↓42.8%
-$115.15M ↓102.7%
-$56.81M
Interest Expense
$79.89M
$79.89M ↑59.5%
$50.09M ↑177.0%
$18.08M ↓14.3%
$21.11M
$1.45M
Income Tax
$164,000.00
$164,000.00
$3,000.00 ↑175.0%
-$4,000.00 ↓116.7%
$24,000.00
$0.00
Net Income
-$13.23M
-$13.23M ↑90.9%
-$145.23M ↑11.2%
-$163.62M ↓27.1%
-$128.72M ↓122.7%
-$57.80M
EBITDA
$66.74M
$50.32M ↑154.3%
-$92.74M ↑40.7%
-$156.42M ↓48.6%
-$105.26M ↓89.0%
-$55.71M
EPS
-0.52
-0.46 ↑91.0%
-5.12 ↑15.8%
-6.08 ↓33.0%
-4.57 ↓116.6%
-2.11
Shares Out (Diluted)
119.81M
31.34M ↑10.4%
28.38M ↑5.4%
26.92M ↓4.4%
28.16M ↑2.7%
27.43M